Back to company

MedArt ApS: Financial statements 2024

CVR: 41925736

MedArt ApS (CVR 41925736) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,193,702 and a net result of DKK -3,326 compared with DKK 20,471 the year before. That is a decrease of 8.8% compared with the year before. Equity amounted to DKK 1,235,094. The solvency ratio was 36.7%. The company had 5 employees in the financial year.

Gross Profit
2,193,702 kr.
Profit/Loss
-3,326 kr.
Equity
1,235,094 kr.
Total Assets
3,367,457 kr.
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.2 mio.-3 t.1.2 mio.5
2023-2.4 mio.20 t.1.2 mio.5
2022-2.5 mio.12 t.1.2 mio.5
2021-2.2 mio.167 t.1.2 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Events in 2024

MedArt ApS: The 2023 annual report is outApr 29, 2024

MedArt ApS has published its annual report for 2023. Gross profit came to DKK 2,404,111, and the net result was DKK 20,471.

About MedArt ApS

MedArt ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2020. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Ole Stoklund. The company is owned by ADVALIGHT ApS. In 2024, the company reported a gross profit of DKK 2,193,702 and a net result of DKK -3,326 compared with DKK 20,471 the year before. Equity amounted to DKK 1,235,094.

Other financial years